(Q67901666)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author

Athanassios N. Chremos

2

object named as

A N Chremos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

C. A. Dujovne

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

J. L. Pool

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

H. Schnaper

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

R. H. Bradford

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

C. L. Shear

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

J. Higgins

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

M. Downton

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

F. A. Franklin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

D. T. Nash

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1831006

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1831006

4 December 2022

publication date

1 July 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

31 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1831006

full work available at URL

4 December 2022

https://api.elsevier.com/content/article/PII:000293439190053Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

https://api.elsevier.com/content/article/PII:000293439190053Z?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

American Journal of Medicine

4 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

1B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

25S-30S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

19 September 2019

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

Efficacy and long-term adverse effect pattern of lovastatin

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia.

4 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

Clinical experience with lovastatin.

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90053-Z

4 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1831006%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference